
Thomas Ollila
Assistant Professor of Medicine · Alpert Medical School
Credentials: · · · · ·
History
Research
Review · Current Treatment Options in Oncology · 2018 · First of 2 authors · 147 citations
Blood · 2022 · 81 citations
Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma
Review · OncoTargets and Therapy · 2019 · First of 3 authors · Corresponding · 62 citations

24 papers

16 papers

16 papers

12 papers

12 papers · 8 as a resident
- AD
10 papers
- AP
10 papers · 1 as a fellow

10 papers
Clinical trials
- 2026–2029
Site PI · Recruiting · Phase 3
Ono Pharmaceutical Co., Ltd.





